Publications

Publications

Tap into Gubra’s vast production of publications and posters to get the latest knowledge and insights within our focus areas: diabetes, obesity, NASH and gastrointestinal diseases.

Gubra poster: Body-weight lowering agents and their comparative metabolic and hepatic effects in obese mouse models of non-alcoholic fatty liver disease and steatohepatitis

Read more...

Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function

Read more...

Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats

Read more...

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice

Read more...

Novel insight into the distribution of L-cells in the rat intestinal tract

Read more...

Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats

Read more...

Characterisation of age-dependent beta cell dynamics in the male db/db mice

Read more...

Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion

Read more...

The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice

Read more...

The sodium glucose cotransporter type 2 inhibitor empagliflozin preserves β-cell mass and restores glucose homeostasis in the male zucker diabetic fatty rat

Read more...

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Read more...

Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (Macaca mulatta) Brain

Read more...

The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease

Read more...

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents

Read more...

The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice

Read more...

Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass

Read more...

Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease

Read more...

The endogenous preproglucagon system is not essential for gut growth homeostasis in mice

Read more...

Mouse models of nonalcoholic steatohepatitis in preclinical drug development

Read more...

Neuromedin U inhibits food intake partly by inhibiting gastric emptying. Peptides.

Read more...

Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy

Read more...

Featured publications

Gubra poster: Body-weight lowering agents and their comparative metabolic and hepatic effects in obese mouse models of non-alcoholic fatty liver disease and steatohepatitis

Read more...

Mouse models of nonalcoholic steatohepatitis in preclinical drug development

Read more...

Neuromedin U inhibits food intake partly by inhibiting gastric emptying. Peptides.

Read more...

Sign up for Gubra Insights

Subscribe and get latest science insights from Gubra.

Sign up

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

info@gubra.dk
+45 3152 ­2650